Enumeral Biomed Cash Flow - Annual (OTCMKTS:ENUMQ)

Add to My Stocks
$0 $0 (0%) ENUMQ stock closing price May 31, 2018 (Closing)

The financial analysis of ENUMQ requires an investor to check the cash flows for Enumeral Biomed. Financials statements like the Enumeral Biomed income statement and Enumeral Biomed balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Enumeral Biomed cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Enumeral Biomed had cash and cash equivalents of $3.59M at the beginning of the year and $3.16M at year end for 2016. Enumeral Biomed has a negative cash and cash equivalents change of $-0.43M.

View details of Enumeral Biomed cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20162015201420132012
Net Income Cash Flow
-11.85M3.29M-8.17M-3.86M-
Depreciation Depletion Amortization Cash-Flow1.11M----
Net Increase (Decrease) in Assets Liabilities-0.09M-0.08M--0.13M-
Cash From (used in) Discontinued Operations-----
Other Adjustments Net5.16M-13.11M2.16M--
Net Cash from (used by) Operating Activities
-5.67M-9.28M-5.23M-3.3M-
Increase (Decrease) in Prop Plant And Equipment--1.05M-0.56M-0.06M-
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-3.02M-3.54M--
Other Cash Inflow (Outflow) from Investment Activities-----
Net Cash from (used by) Investment Activities
-1.97M-4.11M-0.06M-
Issuance (Purchase) of Equity Shares2.94M-19.85M2.6M-
Issuance (Repayment) of Debt Securities2.28M--0.3M--
Increase (Decrease) in Bank & Other Borrowings----0.71M-
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-----
Net Cash from (used by) Financing Activities
5.23M-19.54M1.88M-
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
-0.43M-6.86M10.19M-1.48M-
Cash & Equivalents at Beginning of Year3.59M10.46M-1.74M-
Cash & Equivalents at Year End3.16M3.59M10.46M--
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Shire financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Enumeral Biomed stock price history and Enumeral Biomed stock comparison chart inevitably reflect its cash flow situation.

  • Enumeral Biomed had a Net Change in Cash and Cash Equivalents of $-0.43M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Enumeral Biomed stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Enumeral Biomed reported a negative operating cash flow of $-5.67M for 2016 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for ENUMQ in last 2016 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $5.23M for Enumeral Biomed.

Key Financial Ratios For Enumeral Biomed Cash Flow

Annual Cash Flow Statements For ENUMERAL BIOMEDICA COM USD0.001 Peers

Imagenetix cash flow, Pacifichealth cash flow, Shire cash flow